Polycythemia Vera Clinical Case Discussion: When to Intervene with JAKAFI (ruxolitinib) & MONJUVI (TASITAMAB-CXIX) IN COMBINATION WITH LENALIDOMIDE: A 2L Outpatient Targeted Immunotherapy for Adult Patients with R/R DLBCL Who are Not Eligible for Transplant
Presented By:
Patricia Manea, RN, BSN,OCN
Incyte Corporation
Date/Time:
Thursday, August 1, 2024
Location:
Fleming's Prime Steakhouse
2525 West End Avenue
Nashville, TN 37203
